Physician profile
George M Donahue
NPI 1710964325
$6,024.79
in general payments reported to CMS, 2019-2025
33 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,903 · 2020: $629 · 2021: $1,469 · 2022: $554 · 2023: $683 · 2024: $469 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463 · Education: $6.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.01 |
| Education | $6.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,257.10 | 2019-2025 | Airsupra, Breztri, Bevespi Aerosphere |
| Pfizer INC. | $940.66 | 2019-2025 | |
| Lilly USA, LLC | $502.87 | 2020-2024 | Jardiance, Emgality, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.91 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $370.07 | 2019-2023 | |
| Astellas Pharma US INC | $276.33 | 2019-2023 | Veozah, Myrbetriq |
| Allergan, INC. | $267.67 | 2019 | |
| Sanofi-Aventis U.S. LLC | $249.79 | 2019-2021 | |
| Glaxosmithkline, LLC. | $206.31 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $205.01 | 2019-2023 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.87 | 2021-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $175.33 | 2019-2024 | Eliquis |
| Amarin Pharma, INC. | $156.07 | 2019 | |
| Mylan Specialty L.P. | $125.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $112.24 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $103.41 | 2020-2021 | |
| Optinose US, INC. | $98.78 | 2019-2021 | |
| Exact Sciences Corporation | $62.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Neurocrine Biosciences, INC. | $55.69 | 2023 | Ongentys |
| Stryker Corporation | $34.43 | 2020 | |
| Avanir Pharmaceuticals, INC. | $29.77 | 2021 | |
| Merck Sharp & Dohme LLC | $29.04 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $27.82 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $20.98 | 2023 | |
| Seqirus USA INC | $20.12 | 2025 | Flucelvax, Fluad |
| Paratek Pharmaceuticals, INC. | $19.23 | 2025 | Nuzyra |
| Horizon Therapeutics Plc | $18.21 | 2020 | |
| Azurity Pharmaceuticals, INC. | $16.70 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $16.69 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.65 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.14 | 2020 | |
| Snap Diagnostics LLC | $12.82 | 2023 | Snap Diagnostics Study |
| Almatica Pharma LLC | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Donahue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.